Market revenue in 2022 | USD 4,635.5 million |
Market revenue in 2030 | USD 11,934.9 million |
Growth rate | 12.5% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.37% in 2022. Horizon Databook has segmented the Asia Pacific molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
The Genome Asia consortium launched Genome Asia 100K project in February 2016, which includes a whole-genome sequencing reference dataset from 64 Asian countries, 1,739 individuals of 219 population groups. The first phase of this project was focused on creating reference genomes for all major Asian ethnic groups.
Nanyang Technological University, Singapore and Med Genome are the founding partners of this consortium. Furthermore, increasing application of molecular diagnostics in the region also increases the demand for molecular biology enzymes, kits, and reagents in the region.
To improve precision medicine through molecular genetics testing, CIRCULOGENE partnered with CIRCULOGENE Asia Pacific Limited, New Zealand for further expanding its molecular diagnostics business in the region. Such companies are anticipated to propel the market growth in the near future.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account